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A study on the effect of intraoperative continuous positive airway 
pressure (CPAP) on the postoperative pulmonary function 
in overweight patients undergoing lower limb, lower abdominal 
or vaginal surgeries under spinal anesthesia
Abstract
Introduction: Spinal anaesthesia, supine position and higher BMI are risk factors for pulmonary atelectasis. NIV, PEEP and CPAP 
are employed in ICU’s to treat atelectasis postoperatively. However, we wanted to investigate whether CPAP was protective 
against atelectasis when used intraoperatively, in high risk patients. 
Material and methods: This study was a randomized controlled trial. Overweight patients, who were to undergo surgeries under 
spinal anesthesia were included in the study. After informed consent, 126 patients underwent preoperative pulmonary function 
tests (PFT: FEV1, FVC, PEFR). Following the onset of spinal anaesthesia patients were randomised into group E (n = 63, received 
CPAP) and control group, group C ( n =63, received nil intervention). Postoperative PFT was done at 20 minutes, 1 hour, 2 hours 
and 3 hours after surgery. Patients were followed up till discharge for pulmonary complications. 
Results: We observed significant reduction in pulmonary function (FEV1, FVC and PEFR) postoperatively compared to base-
line. CPAP group had better pulmonary function when compared to control group, the difference being significant 20 minu-
tes after the surgery(p < 0.05). No postoperative pulmonary complication was reported among the 126 patients studied. 
Conclusion: Intraoperative use of CPAP in overweight patients undergoing surgeries under spinal anaesthesia could be beneficial 
in improving pulmonary function in the immediate post-operative period.
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Introduction
Postoperative pulmonary complication (PPC) 
is a recognised event. Incidence of postoperative 
atelectasis is 20–69% and that of postoperative 
pneumonia is 9 to 40% [1]. The duration of hospi-
tal admission, morbidity and mortality increase 
significantly in patients with respiratory dysfunc-
tion. Age ≥ 60 years, body mass index (BMI) ≥ 27, 
history of cancer, impaired cognitive function 
in the preoperative setting, upper abdominal, or 
both upper/lower abdominal incision site and 
positive smoking history within the past 8 weeks 
are the identified predictors [2] of development 
of postoperative pulmonary dysfunction.
Overweight and obese individuals have 
higher intraabdominal pressure which can lead 
to basal atelectasis [3, 4]. Increased chest wall 
stiffness causes higher respiratory elastance in pa-
tients with obesity [5]. Atelectasis which worsens 
during general anaesthesia and do not disappear 
after surgery is documented in obese patients. 
Supine position during surgery causes ce-
phalad movement [6] of the diaphragm and 
reduction in cross-sectional area of the thorax. 
Relative pooling of blood in the thorax during 
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supine position reduces the pulmonary volume. 
For a wide range of lower limb, abdominal, 
vaginal and inguinal surgeries, general as well as 
spinal anaesthesia are equally feasible. Atelecta-
sis during both general and spinal anaesthesia 
are well documented [7].
The application of positive end-expiratory 
pressure (PEEP) is effective against atelectasis 
in general anaesthesia [8]. In spontaneously 
breathing awake patients, PEEP can be provided 
using EzPAP® [9, 10]. Overweight patients in 
supine position under spinal anaesthesia are 
definitely a high-risk group of development of 
postoperative atelectasis. 
The aim of our study was to assess whether 
administering EzPAP® intraoperatively to over-
weight patients improved their pulmonary func-
tion postoperatively, compared to controls, after 
surgeries under spinal anaesthesia. 
Materials and methods
This study was an open-label randomised 
control trial undertaken in the Department of 
Anaesthesiology and Critical Care, Jawaharlal 
Institute of Postgraduate Medical Education and 
Research (JIPMER) between January 2015 and 
May 2016. A total of 126 American Society of 
Anaesthesiology (ASA) Class 1 and 2 patients in 
the age group of 18 to 60 years with BMI between 
25 to 30 undergoing elective lower limb, inguinal 
or vaginal procedures under spinal anaesthesia 
were included in the study after approval from the 
institute ethics committee, Clinical Trial Registry 
of India (CTRI), registration and written informed 
consent from participants. Patients who were 
claustrophobic, pregnant, having cardiorespira-
tory diseases causing poor effort tolerance were 
excluded from the study. Inability to comprehend 
the application of EzPAP® was also an exclusion 
criterion.
During preoperative assessment, the procedu-
re was explained and the use of a PFT machine was 
demonstrated to all participants. All the patients 
received standard premedication as per institute 
protocol which included famotidine 20 mg and 
diazepam 5 mg at night followed by 20 mg famoti-
dine, 5 mg diazepam and 10 mg metoclopramide 
in the morning unless otherwise specified.
In the operation theatre, in supine position, 
standard ASA monitors were attached. They 
included ECG, pulse oximetry and Non-Invasive 
Blood Pressure monitoring. Baseline pulmonary 
function test (PFT) was done using a handheld 
spirometer (190513 MIR Spirobank G). A nose 
clip was used during the spirometry, which was 
performed by the anaesthesiologist assigned to 
the case. Forced expiratory volume in the first 
second (FEV1), forced vital capacity (FVC) and 
PEFR were noted down. Each time spirometry 
was repeated three times in supine position and 
the best of the three results was taken as per the 
European Respiratory Society guidelines [11]. 
Spinal anaesthesia was administered with 
hyperbaric bupivacaine and block height was 
documented. After the onset of spinal anaesthe-
sia, the anaesthesia resident assigned to the ope-
rating table opened a sealed opaque envelope. 
The envelope contained a random number which 
was computer-generated by block randomisation. 
The block sizes were 4, 6 and 8, and the original 
generated list contained 130 numbers. The list 
was created and sealed with the help of an inde-
pendent anaesthesiologist, unrelated to the study.
PEEP was provided during the study by 
the anaesthesiologist assigned to the case using 
a device called EzPAP® (PORTEX® EzPAP® Po-
sitive Airway Pressure System, manufactured by 
Smiths Medical). It is an FDA approved device, 
for treatment and prevention of atelectasis and 
mobilisation of endobronchial secretions. The 
device consists of a mouthpiece, an air inlet, 
pressure port with a cap, gas inlet port with tu-
bing and a manometer. Once EzPAP® is connec-
ted to the oxygen flow meter from the wall port, 
the patient has to breathe in through the mouth 
piece. Oxygen flow is then adjusted to generate 
a PEEP of 10 cm H2O (9), which is measured by 
the manometer. Airflow to the convex parts of the 
PEEP valve causes it to attach and adhere due to 
coanda effect, generating PEEP. A nose clip is not 
a part of the device and was not used during the 
study. EzPAP® was administered throughout the 
duration of the surgery. Fixed CPAP of 10 cm H2O 
was used for better comparability, as per protocol.
Intraoperatively, the group E (n = 63) re-
ceived EzPAP® and the control group, group C 
(n = 63) received oxygen by face mask at a flow 
rate of 6 L/min. 
Throughout the surgery, at 5 minutes in-
tervals, noninvasive blood pressure, ECG and 
SpO2 were documented.
Postoperatively, PFT was repeated in supine 
position using the same spirometer, as before, 
at 20 minutes, 1 hour, 2 hours and 3 hours after 
the end of surgery. This was done after assessing 
the visual analogue scale (VAS) score for pain. 
PFT was measured only when VAS score was 
less than 2 to remove the confounding effect of 
pain on PFT. Rescue analgesics (paracetamol and 
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ketorolac) were used to ensure adequate analge-
sia whenever VAS score was > 2. Postoperative 
nausea and vomiting were documented. Patients 
were followed up clinically till discharge for po-
stoperative pulmonary complications. 
Postoperative pulmonary complication was 
defined as the development of pneumonia any time 
before discharge. Diagnosis was based on the presen-
ce of new onset of cough with expectoration, fever 
(temperature > 38.3°C), leucocytosis (total leucocyte 
count > 20,000/µL) or leucopenia (total leucocyte 
count < 4000/µL) and radiological infiltrates. 
Sample size calculation and statistical analy-
sis were done by using SPSS version 13.0 so-
ftware. Sample size calculation was based on 
a similar study [7] which documented reduction 
in FEV1, FVC and PEFR following spinal ana-
esthesia. Distribution of data was tested using 
one- sample Kolmogorov Smirnov test. Categorical 
data were expressed as frequency and percentages 
and were compared by using chi-square test or 
Fischer’s exact test. The data on age, anthropo-
metric parameters, level of pain and pulmonary 
function parameters were expressed as mean 
with standard deviation or median with range 
and were compared with the help of indepen-
dent student t test/Mann-Whitney U test/one-way 
analysis of variance or Kruskall-Wallis test based 
on the distribution of data and the number of 
groups. Spinal block height was expressed as 
median with interquartile range and analysed 
using the Mann-Whitney U test. The statistical 
significance of the longitudinal changes in FEV1, 
FVC and PEFR in each group was calculated by 
one-way repeated measures of ANOVA. The lon-
gitudinal changes over time between the groups 
were analysed using two-way repeated measures 
of ANOVA. Post hoc analysis of ANOVA results 
was performed using the Tukey Test in SPSS so-
ftware. Statistical analysis was carried out at 5% 
level of significance and 80% power, and p value 
< 0.05 was considered as significant. 
Results
A total of 150 patients were assessed for eli-
gibility. 4 individuals did not fit into inclusion 
criteria, 10 persons opted not to participate in 
the study and 10 patients had failed spinal ana-
esthesia. Finally, 126 subjects were included in 
the study. 63 patients were randomly allotted to 
the test group and control group. Consort Diagram 
is represented as Figure 1. Demographic charac-
teristics are represented in Table 1.
The duration of surgery was found to be 
significantly different (P < 0.01) between the 
Figure 1. Consort diagram
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Table 1. Distribution of age, sex, body mass index (BMI) and duration of surgery between the two groups
Parameter E group C group P value
Age (Years — mean ± SD) 39.7 ± 9.01 38.06 ± 9.1 0.29
Sex (male:female %) 39.7 ± 60.3 42.9 ± 57.1 0.717
Duration of surgery (hours — mean ± SD) 1.81 ± 0.76 1.46 ± 0.69 0.007
BMI (Kg/m² — mean ±  SD) 26.63 ± 1.11 26.34 ± 1.03 0.124
two groups with the EzPAP® group (group E) 
undergoing surgeries for a longer duration. End 
operative block height among the group E was 
comparable to the group C (P = 0.633). Mean 
end operative block height was T8 (T8–T10) in 
both the groups. 
22.2% of patients in each group required 
analgesia before doing PFT postoperatively. 
Either paracetamol (19/28–67.85%) or ketorolac 
(9/28–32.15%) was used as analgesic. None of the 
patients had postoperative nausea or vomiting.
FEV1, FVC and PEFR were found to be signi-
ficantly better among the group E compared to 
the group C, 20 minutes after surgery (p < 0.05). 
Baseline PFT parameters and those at 1 hour, 
2 hours and 3 hours after surgery were compa-
rable between the groups (Table 2, Figures 2–4).
None of the patients in either group had 
SpO2 values <95% at any point of time. SpO2 trend 
in either group during the first hour of surgery is 
represented in Figure 5. The distribution of the 
type of surgery is illustrated in Figure 6.
There is a significant fall in FEV1, FVC and 
PEFR after spinal anaesthesia and surgery, me-
asured at the end of 20 minutes, 1 hour, 2 hours 
and 3 hours postoperatively when compared to 
baseline in the E group as well as C group (Table 3, 
4). None of the patients developed postoperative 
pulmonary complications till discharge. 
Table 2. Comparison of FEV1, FVC, PEFR between the groups at different time points
FEV1* FVC* PEFR*
Time point Group E Group C P value Group E Group C P value Group E Group C P value
Baseline 3.3 ± 0.41 3.3 ± 0.4 0.8 3.97 ± 0.48 4.05 ± 0.52 0.39 500 ± 75.9 505 ± 85.1 0.71
20 minutes 3 ± 0.4 2.82 ± 0.4 0.01* 3.68 ± 0.46 3.5 ± 0.51 0.046* 468 ± 70 440 ± 78.2 0.035*
1 hour 3.1 ± 0.38 2.97 ± 
0.39
0.18 3.75 ± 0.48 3.67 ± 0.5 0.38 475 ± 71.2 458 ± 77 0.2
2 hours 3.1 ± 0.38 3.11 ± 0.4 0.8 3.82 ± 0.48 3.82 ± 0.5 0.98 485 ± 71.98 476 ± 80.4 0.51
3 hours 3.2 ± 0.38 3.21 ± 0.4 0.98 3.9 ± 0.5 3.9 ± 0.5 0.94 492 ± 72.55 488 ± 82.3 0.76
*All results in mean ± SD (L). FEV1 — forced expiratory volume in the first second; FVC — forced vital capacity; PEFR — peak expiratory flow rate
Discussion
Overweight patients have higher chances 
of atelectasis and postoperative complications 
compared to normal weight patients [12]. Spinal 
anaesthesia and supine position are also inde-
pendent risk factors for reduction in pulmonary 
function. Positive end expiratory pressure im-
proves pulmonary function by lung expansion 
in patients undergoing surgeries under general 
anaesthesia. Given the current data by World 
Health Organization (WHO), nearly 40% of the 
adult population in the world is overweight. We 
wanted to address the effects of spinal anaesthesia 
and potential results of PEEP on the pulmonary 
function of overweight patients [13] undergoing 
surgeries. 
We recruited 126 overweight patients (BMI 
25–30 kg/m²) who underwent lower limb, vaginal 
or inguinal surgeries under spinal anaesthesia. 
Meira et al. [14] and Sternberg et al. [7] have 
documented atelectasis in overweight patients 
undergoing surgeries under spinal anaesthesia. 
But the application of EzPAP® in overweight 
patients to prevent atelectasis is not well studied.
Both groups of patients were comparable in 
terms of distribution of age (group E vs  group C: 
39.7 ± 9.01 years’ vs 38.06 ± 9.01 years; p > 0.05), 
sex (M:F  group E vs group C: 39.7 ± 60.3 vs 42.9 ± 
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Figure 2. Comparison of FEV1 (L) between group E and group C at different time points
Figure 3. Comparison of FVC between group E and group C at different time points
57.1; p > 0.05) and BMI (group E vs group C 
26.63 ± 1.11 vs 26.34 ± 1.03; p > 0.05). BMI in 
both groups were only marginally higher than 
that of normal as our study focused strictly on 
overweight patients. 
The test group had a significantly longer du-
ration of surgery (1.81 ± 0.76 hours) compared 
to the control group (1.46 ± 0.69 hours; p < .05). 
A possible explanation is that setting up EzPAP® 
and ensuring the patient compliance and com-
fort during the procedure might have caused the 
delay. However, end operative block height in 
the test group as well as the control group was 
T8 (T8–T10) with a p value of 0.63, which indi-
cates that irrespective of the duration of surgery, 
end operative block heights were comparable. 
All patients were pain-free throughout the 
surgery and did not require intraoperative anal-
gesics. Patients belonging to both groups were 
haemodynamically stable throughout the surgery.
All PFT measurements including baseline 
measurement were done in supine position to en-
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Figure 5. Variation of SpO2 with time in group E and group C during surgery
sure uniformity. Both groups had significant fall 
in PFT, i.e. FEV1, FVC and PEFR when compared 
to baseline at 20 minutes, 1 hour, 2 hours and 
3 hours after the surgery. This is in accordance 
with previous studies which have documented 
reduction in pulmonary function after spinal 
anaesthesia [7, 11, 14].
FEV1 , FVC and PEFR declined in both groups 
over time, though the difference was significant 
only at 20 minutes. However, PFT values declined 
less in the group E, which could be attributed to 
better lung expansion in in this group. Another stu-
dy in cardiology ICU setting [15] has demonstrated 
similar findings in a group of postoperative cardiac 
surgery patients receiving CPAP, though they were 
receiving CPAP for a significantly longer duration.
A limitation we felt during the study was 
the lack of PaO2 measurements for comparison. 
However, this aspect was considered and decided 
against during the planning stage as we felt it was 
unethical to take arterial prick samples from awa-
ke ASA1 and 2 patients when it did not directly 
benefit them in terms of management. Further-
more, FRC couldn’t be assessed as it was unsafe 
to mobilise immediate postoperative patient to 
PFT lab for getting the FRC done. The patients 
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Figure 6. The distribution of the type of surgery
Table 3. Comparison of FEV1, FVC, PEFR at different time points when compared to baseline in group E
Baseline Time points FEV1 — mean with SD (L) P value
FEV1*
3.28 ± 0.412
20 minutes 3 ± 0.4 < 0.001*
1 hour 3.06 ± 0.38 < 0.001*
2 hours 3.13 ± 0.38 < 0.001*
3 hours 3.21 ± 0.38 0.01*
FVC*
3.97 ± 0.48
20 minutes 3.68 ± 0.46 < 0.001*
1 hour 3.75 ± 0.48 < 0.001*
2 hours 3.82 ± 0.48 < 0.001*
3 hours 3.9 ± 0.5 0.021*
PEFR*
500.16 ± 75.85
20 minutes 467.92 ± 70 < 0.001*
1 hour 474.94 ± 71.2 < 0.001*
2 hours 484.52 ± 71.98 < 0.001*
3 hours 492.16 ± 72.55 0.01*
*All results in mean ± SD (L). FEV1 — forced expiratory volume in the first second; FVC — forced vital capacity; PEFR — peak expiratory flow rate
were not evaluated by lung ultrasound for ate-
lectasis due to lack of availability of a dedicated 
ultrasound machine for the study. Similarly, they 
were not assessed for obstructive sleep apnoea by 
polysomnography due to practical difficulties of 
high caseload in the sleep lab and unavailability 
of the same for 126 patients. As we included only 
overweight patients belonging to ASA 1 and 2 in 
the study, the results might not be generalisable 
to morbidly obese or elderly patients with mul-
tiple comorbidities. Postoperative pulmonary 
complications might not have developed in our 
study population probably because our study was 
limited to overweight patients without significant 
comorbidities. 
Conclusions
Intraoperative use of EzPAP® in overweight 
patients undergoing surgeries under spinal ana-
esthesia may improve pulmonary function in the 
immediate postoperative period. However, further 
studies are needed to evaluate the impact it has 
on arterial PaO2 as well as FRC. Furthermore, 
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patients. Acta Anaesthesiol Scand. 2005; 49(7): 940–948, doi: 
10.1111/j.1399-6576.2005.00754.x.
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latory strategies for prevention of pulmonary atelectasis in obe-
se patients undergoing laparoscopic bariatric surgery. Anesth 
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stoperative hypoxemia in the recovery room: experiences with 
the new compact system of end-expiratory positive airway 
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dy. J Anesth Clin Res . 2012; 03(08), doi: 10.4172/2155-
6148.1000236.
11. Levy ML, Quanjer PH, Booker R, et al. General practice airways 
group. Diagnostic spirometry in primary care: proposed stan-
dards for general practice compliant with american thoracic 
society and european respiratory society recommendations. 
Primary Care Respiratory Journal. 2009; 18(3): 130–147.
12. Thomas E, Goldman L, Mangione C, et al. Body mass index 
as a correlate of postoperative complications and resource 
utilization. Am J Med. 1997; 102(3): 277–283, doi: 10.1016/
s0002-9343(96)00451-2.
13. World Health Organization. Obesity and overweight. Available 
from: www.who.int/mediacentre/factsheets/fs311/en/. [Last ac-
cessed at May 25th, 2020].
14. Meira M, Carvalho C, Galizia MS, et al. Atelectasis observed by 
computerized tomography after Caesarean section. Br J Ana-
esth. 2010; 104(6): 746–750, doi: 10.1093/bja/aeq090.
15. Regli A, Ungern-Sternberg BS, Reber A, et al. Impact of spi-
nal anaesthesia on peri-operative lung volumes in obese and 
morbidly obese female patients. Anaesthesia. 2006; 61(3): 
215–221, doi: 10.1111/j.1365-2044.2005.04441.x.
16. Borghi-Silva A, Mendes R, Costa F, et al. The influences of 
positive end expiratory pressure (PEEP) associated with phy-
siotherapy intervention in phase I cardiac rehabilitation. Cli-
nics. 2005; 60(6), doi: 10.1590/s1807-59322005000600007.
Table 4. Comparison of FEV1, FVC and PEFR at different time points when compared to baseline in group C
Baseline (L) Time points FVC — mean with SD (L) P value
FEV1*
3.3 ± 0.44
20 minutes 2.82 ± 0.4 < 0.001*
1 hour 2.97 ± 0.39 < 0.001*
2 hours 3.11 ± 0.4 < 0.001*
3 hours 3.21 ± 0.4 0.01*
FVC*
4.05 ± 0.52
20 minutes 3.5 ± 0.51 < 0.001*
1 hour 3.67 ± 0.5 < 0.001*
2 hours 3.82 ± 0.5 < 0.001*
3 hours 3.9 ± 0.5 < 0.001*
PEFR*
505.4 ± 85.14
20 minutes 439.67 ± 78.17 < 0.001*
1 hour 457.86 ± 77 < 0.001*
2 hours 475.48 ± 80.4 < 0.001*
3 hours 487.97 ± 82.27 < 0.001*
*All results in mean ± SD (L). FEV1 — forced expiratory volume in the first second; FVC — forced vital capacity; PEFR — peak expiratory flow rate
combined intraoperative and postoperative use 
of EzPAP® in the same subset of patients might 
sustain the improvement in lung function and 
needs to be evaluated. 
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